go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Ipsen Pharmaceuticals Ltd

Ipsen Pharmaceuticals Ltd
7 Upper Leeson Street, Dublin 4,
Telephone: +353 1 6681377
Fax: +353 1 6602818
Summary of Product Characteristics last updated on medicines.ie: 09/03/2012
SPC Dysport

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 09/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 6.1 - List of excipients
Date of revision of text on the SPC:   01-Jan-2011
Legal Category:   Product subject to medical prescription which may not be renewed (A)

Free-text change information supplied by the pharmaceutical company

Minor changes to format section 4.2, 4.8$0Minor change to wording: section 4.4, 4.6 (heading title)$0$0Major change to section 6.1$0
Updated on 22/09/2011 and displayed until 09/03/2012
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
Date of revision of text on the SPC:   24-Jan-2011
Legal Category:   Product subject to medical prescription which may not be renewed (A)

Free-text change information supplied by the pharmaceutical company

Changed to read Dysport 500 units powder for solution for injection
Updated on 16/07/2009 and displayed until 22/09/2011
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 10 - Date of revision of the text
  • Change to section 4 - Clinical particulars
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
Date of revision of text on the SPC:   01-Feb-2009
Legal Category:   Product subject to medical prescription which may not be renewed (A)

Free-text change information supplied by the pharmaceutical company

4.1 New indication - Persistent sever primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment

4.2 Axillary Hyperhidrosis - Posology and method of administration

4.4 Special Warnings and precautions for use - Primary Axillary Hyperhidrosis

4.8 Undesirable effects - Axillary Hyperhidrosis

10. Date of approval / revision of SPC
Updated on 21/02/2008 and displayed until 16/07/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 21/02/2008 and displayed until 21/02/2008
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable effects
Date of revision of text on the SPC:   01/2008
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Changes to Undesirable Effects, approved by IMB January 2008.
Updated on 13/09/2007 and displayed until 21/02/2008
Reasons for adding or updating:
  • Change to section 6.3 - Shelf life
Date of revision of text on the SPC:   03/2005
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Change to Shelf Life from 15 to 24 months
Updated on 23/08/2006 and displayed until 13/09/2007
Reasons for adding or updating:
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   10/2004
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Change to Date of Partial Revision of Text
Correction of Spelling/Typing Errors
Updated on 19/05/2005 and displayed until 23/08/2006
Reasons for adding or updating:
  • Change to section 10 - Date of revision of the text
Updated on 16/08/2003 and displayed until 19/05/2005
Reasons for adding or updating:
  • New SPC for medicines.ie
Updated on 30/06/2003 and displayed until 16/08/2003
Reasons for adding or updating:
  • New SPC for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Clostridium botulinum type A toxin-haemagglutinin complex

Versions

 
09/03/2012 to Current
22/09/2011 to 09/03/2012
16/07/2009 to 22/09/2011
21/02/2008 to 16/07/2009
21/02/2008 to 21/02/2008
13/09/2007 to 21/02/2008
23/08/2006 to 13/09/2007
19/05/2005 to 23/08/2006
16/08/2003 to 19/05/2005
30/06/2003 to 16/08/2003
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo